Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price dropped 0.2% on Tuesday . The stock traded as low as GBX 9 ($0.12) and last traded at GBX 9.23 ($0.12). Approximately 148,044 shares were traded during trading, a decline of 35% from the average daily volume of 226,487 shares. The stock had previously closed at GBX 9.25 ($0.12).
Abingdon Health Trading Down 0.2 %
The company has a 50 day simple moving average of GBX 9.80 and a two-hundred day simple moving average of GBX 10.21. The company has a debt-to-equity ratio of 55.57, a quick ratio of 1.96 and a current ratio of 1.79. The company has a market cap of £17.49 million, a PE ratio of -923.00 and a beta of 0.14.
Abingdon Health Company Profile
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Stories
- Five stocks we like better than Abingdon Health
- What is a Stock Market Index and How Do You Use Them?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is Short Interest? How to Use It
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is the S&P 500 and How It is Distinct from Other Indexes
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
